Viewing Study NCT06688656


Ignite Creation Date: 2025-12-24 @ 11:18 PM
Ignite Modification Date: 2026-01-01 @ 5:52 AM
Study NCT ID: NCT06688656
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-11-14
First Post: 2024-11-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Chemotherapy Sequentially Combined with Sintilimab in Resectable EGFR-Mutant NSCLC
Sponsor: Shanghai Chest Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module